Investors who lost money on GSK plc(GSK) should contact Levi & Korsinsky about pending Class Action - GSK
NEW YORK, NY / ACCESS Newswire / February 18, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a ...
Gilead’s lenacapavir moves closer to FDA approval for HIV PrEP use
Lenacapavir is already approved under the name Sunlenca as an HIV treatment for patients resistant to other medication ...
Cosmos Health Inc.: Cosmos Health Announces It will not Proceed with an Offering Under Its Form S-1
CHICAGO, IL / ACCESS Newswire / February 18, 2025 / Cosmos Health Inc. ("Cosmos Health" or the "Company') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovat ...
Le Lézard15h
U.S. FDA Accepts Gilead's New Drug Applications for Twice-Yearly Lenacapavir for HIV Prevention Under Priority Review
Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) submissions for lenacapavir?the company's twice-yearly injectable HIV ...
Taho Pharma’s apixaban oral strips equivalent to Eliquis in pivotal trial
Taho Pharmaceuticals’s apixaban-based oral dissolving strips were discovered to be a bioequivalent of Pfizer and ...
Middle East healthcare expansion opens doors for ASX stocks
The Middle East healthcare sector is undergoing rapid expansion presenting opportunities for ASX-listed pharmaceutical medical device and wellness companies.
Daily19h
Aurobindo Pharma arm gets marketing authorisation for Zefylti in EU
Hyderabad: Aurobindo Pharma has announced that the European Commission (EC) has granted marketing authorization in the ...
in.investing.com on MSN1d
Biocon Gets EU Nod for Ustekinumab Biosimilar; Valuation Signals Upside
Biologics Ltd (BBL), a subsidiary of Biocon Limited, has secured a major regulatory milestone with the European Commission ...
Business Wire1d
GSK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that GSK plc Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has bee ...
centerforbiosimilars1d
FDA, EMA Approve Second Pair of Denosumab Biosimilars
The FDA and European Medicines Agency (EMA) granted approval, with interchangeability in the US, to Samsung Bioepis' ...